- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
MEA Hybrid MRI Systems Market Size (2022 to 2027)
The size of the Middle East and Africa Hybrid MRI Systems Market is predicted to grow at a sluggish rate during the forecast period.
Magnetic resonance imaging (MRI) is an advanced healthcare system which is used making pictures of internal parts of the body. Hybrid MRI system means MRI system combined with some other healthcare equipment for extra benefits. MRI Systems combined with Radiography is used to treat infertility patients, MRI combined with MPI gives the possibility of acquiring superficially high quality pictures of tissues or organs inside the body. MRI Combined with PET gives complete insight in to human body without any limitations in any branch of science. MRI/PET is also used for better diagnosis of Breast Cancer. X-ray/MRI Systems facilitate minimum invasive procedure by providing information about anatomy and physiology.
Drivers like developments in MRI techniques, open architecture, Developing Markets, and software Applications, increase in aging population, and development of MRI compatible pacemakers are driving this market. But some of the factors like high cost of MRI systems, draining helium gas deposits, declining reimbursement rates, lack of skilled labor and complexity of machines are restricting the growth of the market. This region has lowest CAGR and lowest share.
This research report on the Middle East and Africa Hybrid MRI Systems Market has been segmented and sub-segmented into the following categories.
By Field Strength:
- Low-to-mid -Field
- High Field
- Very High Field
- Ultra-High Field
By Type:
- X-Ray/MRI
- PET/MRI
- Radiography/MRI
- MPI/MRI
By Application:
- Brain
- Pelvic
- Cardiac
- Breast
- Musculoskeletal
By Country:
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA
Companies playing an active role in the MEA Hybrid MRI Systems Market profiled in the report are Hitachi Medical Corporation (Japan), Toshiba Medical Systems (Japan), Siemens Healthcare (Germany), GE Healthcare (U.K.), and Philips Healthcare (Netherlands).